Maximum quantity allowed is 999
请选择数量
CAS RN: 24386-93-4 | 产品编码: I1156
5-Iodotubercidin
×
![]()
×
| 产品编码 | I1156 |
| 纯度/分析方法 | >98.0%(T)(HPLC) |
| 分子式/分子量 | C__1__1H__1__3IN__4O__4 = 392.15 |
| 外观与形状（20°C） | 固体 |
| 储存温度 | 冷藏 (0-10°C) |
| 储存在惰性气体下 | 存放于惰性气体之中 |
| 应避免的情况 | 空气,加热 |
| CAS RN | 24386-93-4 |
| Reaxys-RN | 4543232 |
| MDL编号 | MFCD00055131 |
技术规格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Volumetric Analysis) | min. 98.0 % |
| NMR | confirm to structure |
物性（参考值）
| 最大吸收波长 | 284 nm (MeOH) |
GHS
相关法规
运输信息
| HS编码* | 2934.99-000 |
应用
5-Iodotubercidin: A General Protein Kinase Inhibitor
5-Iodotubercidin is a potent and competitive adenosine protein kinase inhibitor. It has been reported that 5-iodotubercidin inhibits CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2, PKC, and nucleoside transporter.1-3) 5-iodotubercidin also inhibits LRRK2 (Leucine-rich repeat kinase 2) –G2019S that is a promising therapeutic target for the treatment of Parkinson's disease.4) There is a recent report, that 5-Iodotubercidin inhibits SARS-CoV-2 RNA-dependent RNA polymerase (RdRp).5) (The product is for research purpose only.)
References
- 1) Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor
- 2) Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT MF-2 smooth muscle cells
- 3) Adenosine Kinase Inhibitors. 1. Synthesis, Enzyme Inhibition, and Anti-seizure Activity of 5-Iodotubercidin Analogue
- 4) Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
- 5) 5-Iodotubercidin inhibits SARS-CoV-2 RNA synthesis
TCIMail
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。